Odapt
Odapt is developing a personalized, 3D-printed wafer for ostomy bags. Using a simple 3D scan of the patient's stoma and surrounding skin, the company creates a custom-fit, reusable silicone wafer that prevents leaks, reduces skin complications, and improves user comfort and confidence.
- CEO / Founder
- Ivana Llobet
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- €25K
- Latest Round
- Grant
Technology & Products
Key Products
Custom 3D-printed silicone wafer for ostomy bags
Technological Advantage
The technology allows for a rapid, on-demand manufacturing process that is adaptable to patient needs. The business advantage lies in addressing a major unmet need (leakage and discomfort) in a large market, with a product that enhances user loyalty through personalization and improved outcomes. The reusable nature of the product also introduces a sustainability angle.
Differentiation
Value Proposition
To provide a leak-proof, comfortable, and personalized ostomy care solution that significantly improves the quality of life for users, while also being more sustainable than current disposable options.
How They Differentiate
Odapt differentiates itself from large, established competitors by offering a fully personalized product. While competitors produce a range of standard-sized disposable products, Odapt creates a unique, reusable device for each user, directly addressing the primary problems of poor fit and leakage.
Market & Competition
Target Customers
Patients with stomas (ostomates) who use ostomy bags, and healthcare providers (hospitals, clinics) that serve them.
Industry Verticals
Healthcare, Medical Devices
Competitors
Coloplast; Hollister Incorporated; ConvaTec
Growth & Milestones
Growth Metrics
Winner of the Formnext 2023 Start-up Challenge; BASF Forward AM Innovation Award People's Choice (€25K). Project under development; public waiting list for first trial; not yet commercially available.
Major Milestones
Founded in 2022 (LinkedIn company)., Elisava master's project → custom 3D-printed silicone ostomy wafer prototype., BASF Forward AM Innovation Award People's Choice €25K (2022)., Formnext 2023 Start-up Challenge winner., CEO Ivana Llobet: Stanford Biodesign Innovation Fellowship (2023–24)., Product still under development; waiting list open on odapt.org as of 2026.
Notable Customers
Not yet commercially available; currently in the trial phase.